3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea
TL;DR: 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea (CAS 372152-22-2) is a chemical compound with molecular formula C23H28Cl2N4O3 and molecular weight 478.15 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea
Also Known As: 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea, 3-(4-chlorophenyl)-1-(3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl)-1-hydroxyurea
| Molecular Formula | C23H28Cl2N4O3 |
|---|---|
| Molecular Weight | 478.15 g/mol |
| LogP | 6.4536 |
| Topological Polar Surface Area | 76.12 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 3 |
| Rotatable Bonds | 7 |
| Exact Mass | 478.15384 |
| Heavy Atoms | 32 |
| Complexity | 950.7188 |
Chemical Identifiers
| CAS Number | 372152-22-2 |
|---|---|
| SMILES | CCCCCN1C(=O)N(C(C1(C)C)N(C(=O)NC2=CC=C(C=C2)Cl)O)C3=CC=C(C=C3)Cl |
Product Overview
3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea (CAS 372152-22-2), with molecular formula C23H28Cl2N4O3 and molecular weight 478.15 g/mol. IUPAC: 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea.
Chemical Property Profile of 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea
Property Insights of 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea
The XLogP value of 6.4536 indicates that 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 76.12 Ų falls within the moderate polarity range, balancing permeability and solubility for 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea. Following Lipinski's Rule of Five, 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea has 2 hydrogen bond donor(s) and 3 hydrogen bond acceptor(s), which may warrant consideration for formulation optimization.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea?
The CAS number of 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea is 372152-22-2.
What is the molecular formula of 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea?
The molecular formula of 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea is C23H28Cl2N4O3.
What is the molecular weight of 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea?
The molecular weight of 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea is 478.15 g/mol.
Where can I buy 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea?
You can request a quote for 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea?
Yes, KEHONG BIO provides custom synthesis services for 3-(4-chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-2-oxo-1-pentylimidazolidin-4-yl]-1-hydroxyurea and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.